Identification of a selective glucocorticoid receptor ligand for the treatment of chronic inflammation in type 2 diabetes mellitus

Author：          

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.8, Iss.4, 2014-01, pp. : 1111-1114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Identification of a proliferatoractivated receptor-γ antagonist for the treatment of type 2 diabetes mellitus

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 2, 2015-01 ,pp. : 446-450

Spandidos Publications

Access to resources Recommend Favorite

Decreased expression levels of Nurr1 are associated with chronic inflammation in patients with type 2 diabetes

By                    

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5487-5493

Spandidos Publications

Access to resources Recommend Favorite

NR4A1 is associated with chronic lowgrade inflammation in patients with type 2 diabetes

By                  

Experimental and Therapeutic Medicine, Vol. 8, Iss. 5, 2014-01 ,pp. : 1648-1654

Spandidos Publications

Access to resources Recommend Favorite

Pioglitazone is an effective treatment for patients with poststroke depression combined with type 2 diabetes mellitus

By                

Experimental and Therapeutic Medicine, Vol. 10, Iss. 3, 2015-01 ,pp. : 1109-1114

Spandidos Publications

Access to resources Recommend Favorite

Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 1, 2011-01 ,pp. : 81-84

Spandidos Publications

Access to resources Recommend Favorite